Performance of creatinine and cystatin C-based equations to estimate glomerular filtration rate in African children with sickle cell anemia
- PMID: 41102530
- DOI: 10.1007/s00467-025-06986-w
Performance of creatinine and cystatin C-based equations to estimate glomerular filtration rate in African children with sickle cell anemia
Abstract
Background: Serum creatinine (SCr), the most used biomarker to evaluate glomerular filtration rate (GFR), might be inaccurate in children with sickle cell anemia (SCA). In this context, cystatin C (SCys) could be of interest. This study evaluated the performance of commonly used SCr- and SCys-based estimated GFR (eGFR) equations in African children with SCA.
Methods: This cross-sectional study included 109 steady-state children with SCA aged 3-18 years, from the Democratic Republic of Congo. Measured GFR (mGFR) was obtained using iohexol plasma clearance. eGFR was calculated using commonly used SCr- and SCys-based equations in children. The performance of these equations was evaluated by calculating the bias, precision, and accuracy within 30% (P30) of mGFR.
Results: The mean age of participants was 9.9 ± 4.2 years, and 48.6% were female. The median mGFR was 142 (IQR 119-169) mL/min/1.73 m2. Of the equations studied, the FAS-Age SCr had the lowest bias (0.9 mL/min/1.73 m2). However, the 95% limit of agreement was very wide (-80.3 to + 81.6). SCr failed to rise in an age-dependent manner, reflecting a progressive loss of muscle mass or increased tubular secretion. All SCys-based equations underestimated GFR and failed to detect hyperfiltration, but there was no age-related change in bias.
Conclusion: These data show that all common eGFR equations using SCr or SCys poorly predict mGFR in African children with SCA. SCr-based equations potentially miss a decline in kidney function, which suggests that SCys could be the preferred marker in this population.
Keywords: Creatinine; Cystatin C; Equations; Glomerular filtration rate; Sickle cell anemia.
© 2025. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
Conflict of interest statement
Declarations. Conflict of interest: Pierre Delanaye and Etienne Cavalier are consultants for Nephrolyx. Hans Pottel is a consultant for Bayer. These funders were not involved in the design, analysis, presentation, or interpretation of the study results. None of the other authors have a relevant conflict of interest.
References
-
- Adebayo O, Nkoy A, Cheng C et al (2023) Sickle cell disease: a neglected haemoglobinopathy disorder with a huge global burden. Belg J Hematol 14:41–58
-
- Thomson AM, McHugh TA, Oron AP et al (2023) Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol 10:e585–e599. https://doi.org/10.1016/S2352-3026(23)00118-7 - DOI
-
- Ataga KI, Saraf SL, Derebail VK (2022) The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol 18:361–377. https://doi.org/10.1038/s41581-022-00540-9 - DOI - PubMed - PMC
-
- Adebayo OC, Van den Heuvel LP, Olowu WA et al (2022) Sickle cell nephropathy: insights into the pediatric population. Pediatr Nephrol 37:1231–1243. https://doi.org/10.1007/s00467-021-05126-4 - DOI - PubMed
-
- Zahr RS, Saraf SL (2024) Sickle cell disease and CKD: an update. Am J Nephrol 55:56–71. https://doi.org/10.1159/000534865 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
